CSZIX
Price
$17.72
Change
-$0.15 (-0.84%)
Updated
Oct 6 closing price
Net Assets
8.3B
PRRAX
Price
$28.30
Change
-$0.21 (-0.74%)
Updated
Oct 6 closing price
Net Assets
6.28B
Interact to see
Advertisement

CSZIX vs PRRAX

Header iconCSZIX vs PRRAX Comparison
Open Charts CSZIX vs PRRAXBanner chart's image
Cohen & Steers Real Estate Securities Z
Price$17.72
Change-$0.15 (-0.84%)
VolumeN/A
Net Assets8.3B
Principal Real Estate Securities A
Price$28.30
Change-$0.21 (-0.74%)
VolumeN/A
Net Assets6.28B
CSZIX vs PRRAX Comparison Chart in %
View a ticker or compare two or three
VS
CSZIX vs. PRRAX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSZIX is a Buy and PRRAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSZIX has more cash in the bank: 8.3B vs. PRRAX (6.28B). CSZIX pays higher dividends than PRRAX: CSZIX (2.83) vs PRRAX (2.18). CSZIX was incepted earlier than PRRAX: CSZIX (11 years) vs PRRAX (20 years). PRRAX (1.19) is less costly to investors than CSZIX (0.75). CSZIX is a more actively managed with annual turnover of: 35.00 vs. PRRAX (31.20). CSZIX has a lower initial minimum investment than PRRAX: CSZIX (0) vs PRRAX (1000). CSZIX annual gain was more profitable for investors over the last year : -1.02 vs. PRRAX (-3.62). CSZIX return over 5 years is better than : 33.01 vs. PRRAX (25.50).
CSZIXPRRAXCSZIX / PRRAX
Total Expense Ratio0.751.1963%
Annual Report Gross Expense Ratio0.751.1963%
Fund Existence11 years20 years-
Gain YTD5.8653.154186%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.3B6.28B132%
Annual Yield % from dividends2.832.18130%
Returns for 1 year-1.02-3.6228%
Returns for 3 years35.8626.37136%
Returns for 5 years33.0125.50129%
Returns for 10 years64.7048.58133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HNCRX21.84N/A
N/A
Hartford International Growth R3
VGHCX192.96N/A
N/A
Vanguard Health Care Inv
BQMGX25.25N/A
N/A
Bright Rock Mid Cap Growth Instl
AFDIX58.26N/A
N/A
American Century Large Cap Equity Inv
QRSAX44.27N/A
N/A
FPA Queens Road Small Cap Value Advisor